Physician profile
Peter Roumeliotis
NPI 1942280326
$2,818.52
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $215 · 2021: $73.56 · 2022: $665 · 2023: $140 · 2024: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $349.56 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.44 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $283.46 | 2019 | |
| Amgen INC. | $258.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $239.84 | 2019-2022 | |
| Novo Nordisk INC | $192.93 | 2019-2022 | |
| Amarin Pharma, INC. | $156.14 | 2019-2020 | |
| Abbott Laboratories | $139.86 | 2023 | Freestyle Libre 3 |
| Si-Bone, INC. | $139.72 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $138.82 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $124.99 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.45 | 2024 | |
| Edwards Lifesciences Corporation | $79.42 | 2022 | |
| Philips North America LLC | $53.71 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $36.14 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $24.68 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $23.59 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.69 | 2021 | |
| Almatica Pharma LLC | $16.52 | 2021 | |
| Advanced Respiratory, INC | $15.90 | 2020 | |
| Scilex Pharmaceuticals INC. | $14.40 | 2019 | |
| Gilead Sciences, INC. | $13.56 | 2019 | |
| Sanofi Pasteur INC. | $13.27 | 2019 | |
| Mylan Specialty L.P. | $11.74 | 2019 | |
| Acadia Pharmaceuticals INC | $11.56 | 2019 | |
| Lilly USA, LLC | $11.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Roumeliotis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.